PPARG and Hypertension: We recently showed that restoring Rhobtb1 expression in vascular SMCs in mice with SMC-specific, dominant-negative PPARγ reversed the hypertension, vascular dysfunction, and arterial stiffness caused by the smooth muscle–specific expression of a dominant-negative mutation of PPARγ (14, 16).